134 related articles for article (PubMed ID: 12387051)
1. [Mitiglinide (KAD-1229)].
Kusama H; Shibata N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():559-65. PubMed ID: 12387051
[No Abstract] [Full Text] [Related]
2. [A rapid- and short-acting insulinotropic agent KAD-1229].
Komatsu H; Ohnota H; Koizumi T; Satoh F
Nihon Rinsho; 1997 Nov; 55 Suppl():171-9. PubMed ID: 9434463
[No Abstract] [Full Text] [Related]
3. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
Ohnota H; Koizumi T; Tsutsumi N; Kobayashi M; Inoue S; Sato F
J Pharmacol Exp Ther; 1994 May; 269(2):489-95. PubMed ID: 8182516
[TBL] [Abstract][Full Text] [Related]
4. [Structures and mechanisms for non SU insulin secretagogues].
Kikuchi M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():362-70. PubMed ID: 12387019
[No Abstract] [Full Text] [Related]
5. [The sulfonylurea receptor].
Inagaki N; Gonoi T; Seino S
Seikagaku; 1997 Sep; 69(9):1067-80. PubMed ID: 9364874
[No Abstract] [Full Text] [Related]
6. [Pharmacology of glimepiride].
Satoh Y
Nihon Rinsho; 1997 Nov; 55 Suppl():147-51. PubMed ID: 9434459
[No Abstract] [Full Text] [Related]
7. Absence of exacerbation of myocardial stunning in anesthetized dogs treated with KAD-1229, a novel hypoglycemic agent.
Ichikawa K; Maruyama K; Murakami M; Tsuji A; Yamato T; Kusama H; Kojima M
Eur J Pharmacol; 2001 Nov; 431(3):331-8. PubMed ID: 11730726
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
[TBL] [Abstract][Full Text] [Related]
9. [Molecular basis of oral hypoglycemic sulfonylurea action].
Owecki M; Horst-Sikorska W; Sowiński J
Pol Merkur Lekarski; 2003 Nov; 15(89):445-8. PubMed ID: 14969140
[TBL] [Abstract][Full Text] [Related]
10. The beta-cell K(ATP) channel.
Ashcroft SJ
J Membr Biol; 2000 Aug; 176(3):187-206. PubMed ID: 10931971
[No Abstract] [Full Text] [Related]
11. [ATP-sensitive K+ channel].
Nagashima K
Nihon Rinsho; 2002 Jul; 60 Suppl 7():548-52. PubMed ID: 12238096
[No Abstract] [Full Text] [Related]
12. [Sulfonylurea receptors].
Ishihara H; Oka Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():661-5. PubMed ID: 12430300
[No Abstract] [Full Text] [Related]
13. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
14. Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules.
Nagamatsu S; Ohara-Imaizumi M; Nakamichi Y; Kikuta T; Nishiwaki C
Diabetes; 2006 Oct; 55(10):2819-25. PubMed ID: 17003348
[TBL] [Abstract][Full Text] [Related]
15. Mitiglinide. KAD 1229.
Drugs R D; 1999 Aug; 2(2):114-5. PubMed ID: 10820654
[No Abstract] [Full Text] [Related]
16. [Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: ATP-sensitive potassium channel and insulin secretion].
Seino S
Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1155-7. PubMed ID: 12056011
[No Abstract] [Full Text] [Related]
17. [Sulfonylurea drugs for type 2 diabetes].
Toyota T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
[No Abstract] [Full Text] [Related]
18. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor.
Dunne MJ; Kane C; Shepherd RM; Sanchez JA; James RF; Johnson PR; Aynsley-Green A; Lu S; Clement JP; Lindley KJ; Seino S; Aguilar-Bryan L
N Engl J Med; 1997 Mar; 336(10):703-6. PubMed ID: 9041101
[No Abstract] [Full Text] [Related]
19. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
Sperling MA
N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
[No Abstract] [Full Text] [Related]
20. Mechanism of the insulin-releasing action of alpha-ketoisocaproate and related alpha-keto acid anions.
Heissig H; Urban KA; Hastedt K; Zünkler BJ; Panten U
Mol Pharmacol; 2005 Oct; 68(4):1097-105. PubMed ID: 16014804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
